Search hospitals > Ohio > Cleveland

MetroHealth Medical Center

Claim this profile
Cleveland, Ohio 44109
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Adenocarcinoma
Conducts research for Ovarian Cancer
Conducts research for Breast Cancer
497 reported clinical trials
28 medical researchers
Photo of MetroHealth Medical Center in ClevelandPhoto of MetroHealth Medical Center in Cleveland

Summary

MetroHealth Medical Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Cancer, Recurrence, Adenocarcinoma, Ovarian Cancer, Breast Cancer and other specialties. MetroHealth Medical Center is involved with conducting 497 clinical trials across 714 conditions. There are 28 research doctors associated with this hospital, such as William T. Tse, Kimberly E. Resnick, Jennifer Bailit, MD, and Martha Sajatovic, MD.

Area of expertise

1Cancer
Global Leader
MetroHealth Medical Center has run 101 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Recurrence
Global Leader
MetroHealth Medical Center has run 40 trials for Recurrence. Some of their research focus areas include:
Stage IV
Stage III
Stage I

Top PIs

Clinical Trials running at MetroHealth Medical Center

Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Squamous Cell Carcinoma
Cancer
Spinal Cord Injury
Anal Cancer
Gallbladder Cancer
Multiple Myeloma
Pancreatic Cancer
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Image of trial facility.

Support Program

for Breast Cancer

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at MetroHealth Medical Center?
MetroHealth Medical Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Cancer, Recurrence, Adenocarcinoma, Ovarian Cancer, Breast Cancer and other specialties. MetroHealth Medical Center is involved with conducting 497 clinical trials across 714 conditions. There are 28 research doctors associated with this hospital, such as William T. Tse, Kimberly E. Resnick, Jennifer Bailit, MD, and Martha Sajatovic, MD.
Where is MetroHealth Medical Center located?
To reach MetroHealth Medical Center in Cleveland, Ohio: - Take I-90 W to exit 172A for I-71 N toward downtown. - Use the right 2 lanes to take exit 172A for I-90 W toward Cleveland, then exit 173A for Martin Luther King Jr. Dr. - Turn right onto Martin Luther King Jr. Dr, left onto W 25th St, and right onto MetroHealth Dr. Public transportation options are also available with bus stops and subway stations nearby.
Who should I call to ask about financial aid or insurance network?
**MetroHealth Medical Center Financial Assistance:** - For financial assistance, contact the Financial Eligibility Team at **216-957-2325** or visit [www.metrohealth.org](http://www.metrohealth.org) (click on Financial Assistance). **Insurance-Related Inquiries:** - For insurance questions, call **216-957-3250** (Mon-Thurs 8 a.m. - 8 p.m., Fri 8 a.m. - 5 p.m.) or email [customerservice@metrohealth.org](mailto:customerservice@metrohealth.org).
What insurance does MetroHealth Medical Center accept?
MetroHealth Medical Center accepts a wide range of insurance plans, including but not limited to: - Aetna Better Health OhioRISE - AmeriHealth Caritas Ohio Medicaid - Anthem MediBlue Dual Advantage Special Needs Plan - Buckeye Community Health Plan (BCHP) Medicaid - Carelon Behavioral Health fka Beacon Health Options - Evernorth Behavioral Health fka Cigna Behavioral Health - Cigna Medicare Insurance - CommuniCare Advantage Special Needs Plan - Devoted Health Medicare Advantage - McGregor PACE (fka Concordia Care) - Medical Mutual of Ohio Marketplace - Medical Mutual Medicare Advantage - Optum Behavioral Health (UnitedHealthcare) - PHCS (Private Health Care Systems) PPO - SKYGEN formerly Scion (CareSource, MyCare Ohio, and Molina Medicaid) - UnitedHealthcare Community Plan - UnitedHealthcare HMO (ACA Marketplace) - UnitedHealthcare Medicare Advantage - United Healthcare Special Needs Plan - USA Managed Care Organization (formerly USA Health Network) Valor Health Special Needs Plan Please ensure you bring your photo identification and insurance card for your visit.
What awards or recognition has MetroHealth Medical Center received?
MetroHealth Medical Center in Cleveland, Ohio is renowned for its extensive research efforts, highlighted by its Clinical Research Unit and the MetroHealth Research Institute. The Center for Health Care Research and Policy, a key component of the institution, boasts 11 core faculty members who led or co-led more than 20 active grants, totaling approximately 13 million dollars in 2022. This underscores the significant funding and commitment to advancing medical research at the center.